Nobuichi相关文献与解析，生知库 | 链接生命科学的每一步

Honda, Masashi; Sugawara, Masahiro; Kuribayashi, Nobuichi; Aiso, Yoshitaka; Ito, Shinichi; Ito, Kageki; Kanno, Kazuo; Someya, Yasuhisa; Moriya, Tatsumi

糖尿病

代谢

发表日期：2025

文献求助收藏

Long-term effects of esaxerenone in patients with type 2 diabetes, diabetic kidney disease, and hypertension (JDDM77)

依沙克雷酮对 2 型糖尿病、糖尿病肾病和高血压患者的长期影响 (JDDM77)

期刊:Diabetology International

影响因子:1.2

doi:10.1007/s13340-024-00779-6

Uchida, Daigaku; Sato, Yasunori; Kanatsuka, Azuma; Kuribayashi, Nobuichi; Nakamura, Susumu; Ko, Shigetake; Maegawa, Hiroshi

Exploring the association between self-efficacy for locomotor function and diabetes status in older females: a pilot study

探讨老年女性运动功能自我效能感与糖尿病状况之间的关联：一项初步研究

期刊:Diabetology International

影响因子:1.2

doi:10.1007/s13340-025-00813-1

Aizawa, Fumiya; Kawae, Toshihiro; Kakuda, Akihiro; Ishiguro, Tomoyasu; Kuribayashi, Nobuichi; Kobayashi, Junji

Long-term efficacy and safety of early sitagliptin initiation in individuals with type 2 diabetes: an extension of the SPIKE study

西格列汀早期应用于2型糖尿病患者的长期疗效和安全性：SPIKE研究的扩展研究

期刊:Diabetology International

影响因子:

doi:10.1007/s13340-024-00786-7

Mita, Tomoya; Katakami, Naoto; Yoshii, Hidenori; Onuma, Tomio; Kaneto, Hideaki; Osonoi, Takeshi; Shiraiwa, Toshihiko; Yasuda, Tetsuyuki; Umayahara, Yutaka; Yamamoto, Tsunehiko; Yokoyama, Hiroki; Kuribayashi, Nobuichi; Matsumoto, Kazunari; Gosho, Masahiko; Shimomura, Iichiro; Watada, Hirotaka

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus

在日本2型糖尿病患者中，从二肽基肽酶-4抑制剂转换为口服索玛鲁肽的疗效和安全性

期刊:Diabetology International

影响因子:1.2

doi:10.1007/s13340-024-00734-5

Yoneda, Chihiro; Kobayashi, Junji; Kuribayashi, Nobuichi

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

托格列净对既往无心血管疾病史的2型糖尿病患者动脉粥样硬化进展和主要临床指标的长期影响：UTOPIA试验的2年扩展研究

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-023-01879-4

Katakami, Naoto; Mita, Tomoya; Yoshii, Hidenori; Shiraiwa, Toshihiko; Yasuda, Tetsuyuki; Okada, Yosuke; Kurozumi, Akira; Hatazaki, Masahiro; Kaneto, Hideaki; Osonoi, Takeshi; Yamamoto, Tsunehiko; Kuribayashi, Nobuichi; Maeda, Kazuhisa; Yokoyama, Hiroki; Kosugi, Keisuke; Ohtoshi, Kentaro; Hayashi, Isao; Sumitani, Satoru; Tsugawa, Mamiko; Ryomoto, Kayoko; Kato, Ken; Nakamura, Tadashi; Kawashima, Satoshi; Sato, Yasunori; Watada, Hirotaka; Shimomura, Iichiro

Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study)

5-氨基乙酰丙酸联合铁剂对肌少症患者骨骼肌质量指数和身体机能的疗效和安全性：一项多中心、双盲、随机对照试验（ALADDIN 研究）

期刊:Nutrients

影响因子:5

doi:10.3390/nu15132866

Tamura, Yoshifumi; Kaga, Hideyoshi; Abe, Yasuko; Yoshii, Hidenori; Seino, Hiroaki; Hiyoshi, Toru; Kuribayashi, Nobuichi; Inoue, Ikuo; Watada, Hirotaka

发表日期：2023

文献求助收藏

Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes

日本2型糖尿病患者持续血糖监测指标与动脉硬化程度之间的关联

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-020-01194-2

Wakasugi, Satomi; Mita, Tomoya; Katakami, Naoto; Okada, Yosuke; Yoshii, Hidenori; Osonoi, Takeshi; Kuribayashi, Nobuichi; Taneda, Yoshinobu; Kojima, Yuichi; Gosho, Masahiko; Shimomura, Iichiro; Watada, Hirotaka

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

托格列净对 2 型糖尿病患者动脉僵硬度的影响：前瞻性、随机、开放标签、平行组比较 UTOPIA 试验的预设亚组分析

期刊:Cardiovascular Diabetology

影响因子:10.6

doi:10.1186/s12933-020-01206-1

Katakami, Naoto; Mita, Tomoya; Yoshii, Hidenori; Shiraiwa, Toshihiko; Yasuda, Tetsuyuki; Okada, Yosuke; Torimoto, Keiichi; Umayahara, Yutaka; Kaneto, Hideaki; Osonoi, Takeshi; Yamamoto, Tsunehiko; Kuribayashi, Nobuichi; Maeda, Kazuhisa; Yokoyama, Hiroki; Kosugi, Keisuke; Ohtoshi, Kentaro; Hayashi, Isao; Sumitani, Satoru; Tsugawa, Mamiko; Ryomoto, Kayoko; Taki, Hideki; Nakamura, Tadashi; Kawashima, Satoshi; Sato, Yasunori; Watada, Hirotaka; Shimomura, Iichiro

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

托格列净对2型糖尿病患者治疗相关生活质量的影响

期刊:Diabetes Therapy

影响因子:2.6

doi:10.1007/s13300-021-01125-8

Awareness of the risk factors and interventions for dementia among outpatients with diabetes

提高糖尿病门诊患者对痴呆风险因素和干预措施的认识。

Long-term effects of esaxerenone in patients with type 2 diabetes, diabetic kidney disease, and hypertension (JDDM77)

依沙克雷酮对 2 型糖尿病、糖尿病肾病和高血压患者的长期影响 (JDDM77)

Exploring the association between self-efficacy for locomotor function and diabetes status in older females: a pilot study

探讨老年女性运动功能自我效能感与糖尿病状况之间的关联：一项初步研究

Long-term efficacy and safety of early sitagliptin initiation in individuals with type 2 diabetes: an extension of the SPIKE study

西格列汀早期应用于2型糖尿病患者的长期疗效和安全性：SPIKE研究的扩展研究

Efficacy and safety of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide in Japanese patients with type 2 diabetes mellitus

在日本2型糖尿病患者中，从二肽基肽酶-4抑制剂转换为口服索玛鲁肽的疗效和安全性

Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial

托格列净对既往无心血管疾病史的2型糖尿病患者动脉粥样硬化进展和主要临床指标的长期影响：UTOPIA试验的2年扩展研究

Efficacy and Safety of 5-Aminolevulinic Acid Combined with Iron on Skeletal Muscle Mass Index and Physical Performance of Patients with Sarcopenia: A Multicenter, Double-Blinded, Randomized-Controlled Trial (ALADDIN Study)

5-氨基乙酰丙酸联合铁剂对肌少症患者骨骼肌质量指数和身体机能的疗效和安全性：一项多中心、双盲、随机对照试验（ALADDIN 研究）

Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes

日本2型糖尿病患者持续血糖监测指标与动脉硬化程度之间的关联

Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial

托格列净对 2 型糖尿病患者动脉僵硬度的影响：前瞻性、随机、开放标签、平行组比较 UTOPIA 试验的预设亚组分析

The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus

托格列净对2型糖尿病患者治疗相关生活质量的影响